MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, it's obvious, shorters are desperate, this is about to take off to .02
https://finance.yahoo.com/news/mydx-enters-80-000-mydx360-130000842.html?.tsrc=applewf
The whole thing is great, but this is my favorite part:
Quote:
"The MyDx360 platform makes it incredibly easy for market players to create new high quality tailored formulations that can support their customer's needs. It also speaks to our ability as a company to execute on our vision of creating a brand centric ecosystem powered by community driven data."
Through Black Swans' commitment for alternative to addictive pain killers like the case that was referenced about a star bound athlete dying from addiction to a pain killer leading to heroine addiction. With MYDX licensing and tailoring products for companies to offer alternative natural pain killers to athletes, mediums such as Sports Illustrated will be getting the message out maybe not directly referencing MYDX but that's not as important as the companies being highlighted on Sports Illustrated who are directly connected to MYDX thus creating the correlation.
Excellent reference, now there's a correlation between Sports Illustrated and MYDX through Black Swan.
https://www.cdxlife.com/faqs/what-are-the-shipping-costs-for-us-and-
Quote:
"Currently there are no restrictions to shipping the MyDx within the US or Canada"
Good to know, hadn't really thought there would be a shipping barrier, but it's good to know for sure there isn't one.
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
http://www.wandtv.com/story/35675235/mydx-launches-canadian-national-marketing-campaign-to-promote-transparency-and-prevent-abuse-with-its-cannadx-cannabis-handheld-chemical-analyzer
Good news travels fast and free.
Quote:
"Aphria (APH), one of Canada’s largest licensed Marijuana grower’s, called on the government to determine “clear and enforceable rules to ensure that customers are protected and have access to clean and safe products.” Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
Oh right, it has been released and single use sensors can be purchased through other vendors.
2 cents Monday will just be the beginning of the momentum moving forward. It won't even require 200million volume. Multiple 100million volume days in a row this week could get MYDX to .05 by end of week. With midyear progress report involved, it could get much higher than .05 by end of month and with Q2 report, I would say MYDX investors see what they believed all along. It's just a matter of time. FACTS representing moving MYDX forward.
Not to mention, they believe in MYDX future success.
NO DOUBT
FACTS are in favor of MYDX, speculation is a waste of everyone's time as well as flat out lies.
Hmm, MYDX huge growth potential according to VCI.
http://vci.us.com
Quote:
"VCI invests in small-cap and micro-cap public companies with significant growth potential. Our mission is to utilize our capital and industry resources to help companies expand their business in a way that will ultimately maximize shareholder value."
https://fintel.io/so/us/mydx Another institutional investor reference.
This looks like an institutional investor or at the very least, a company that institutions would trust to invest in indirectly supporting MYDX and remaining discreet:
http://newburghgazette.com/2017/06/18/intu-properties-lon-intu-analyst-target-prices/
Quote:
"INCORPORATED (OTCMKTS:MYDX) had an increase of 11.85% in short interest. 1607 Capital Prns Lc invested in 1.16% or 1.27M shares. Newburgh Gazette"
http://1607capital.com/wordpress/wp-content/uploads/2017/05/FirmOverview1Q17-B.pdf
Quote:
"1607 Capital Partners is an independently owned, boutique investment rm located in Richmond, Virginia. The rm specializes in investing across multiple asset classes using closed-end funds and other similarly discounted investment vehicles. The investment principals of the rm have, on average, nearly two decades of experience speci c to the closed-end fund universe. The rm manages assets primarily for institutional clients, as well as ultra high net worth individuals, through separately managed accounts and commingled limited partnerships."
MYDX trending upward to theoretical infinity, no sign of stopping. Second half 2017 will be solid for MYDX investors going into 2018 I believe.
It's not speculation whether or not I invested in MYDX, I am long and strong. Others who are long and strong are long and strong for the same reason.
FACTS are in favor of MYDX, no speculation necessary.
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
I think the most responsible thing MYDX can do is be an active member in a country that is supporting cannabis/medicinal cannabis and show how MYDX, when effective in Canada, will be effective in US once US decides to support cannabis/medicinal cannabis. That article communicates loud and clear US will follow in Canada's footsteps because good policy is good policy.
If this doesn't tell investors to focus their attention on MYDX, I don't know what will.
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Always good to be optimistic, I believe MYDX market cap will reach $100million. I believe .10 sp with that market cap is a fairer estimate. Does that mean that MYDX won't get .50, with $100M market cap absolutely not. Is this speculation? Absolutely. I wish I had the last 2 minutes of my life back. Here's how I will make it up to myself, do some calculating, figure out what Q2 needs to show financially with sales and compare it to market potential now versus when Q1 came out. See how debt compares to previous quarter and its implications on for what Q3 and 4 could be. Investors will bring market cap by end of year to what investors believe MYDX will be worth by end of 2018 I believe.
FACTS are in favor of MYDX, speculation is a waste of everyone's time.
http://www.wandtv.com/story/35675235/mydx-launches-canadian-national-marketing-campaign-to-promote-transparency-and-prevent-abuse-with-its-cannadx-cannabis-handheld-chemical-analyzer
Good news travels fast and free.
Quote:
"Aphria (APH), one of Canada’s largest licensed Marijuana grower’s, called on the government to determine “clear and enforceable rules to ensure that customers are protected and have access to clean and safe products.” Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."
Good to know SEC is watching.
MYDX midyear progress report due any day before Q2. Should be interesting to know how many preorders of new AquaDX sensor analyzers have been purchased. FACTS are in favor of MYDX. MYDX investors know what they have.
My take on Fins vs. PR: MYDX find are far from perfection and investors are aware of that. This FACT is NOT a threat to investors, however, it is not what makes MYDX attractive to new investors. Sp does not always go down with release of fins, however the sp does tend to go down and I believe it is due to the lack of attracting new investors with far from perfect fins. It is at this time, a lot of attention is on MYDX and is the perfect breeding ground for shorts to have their way with sp. With the release of PRs, I have yet to read a negative PR because there is nothing negative to say about the present function of MYDX products and the future MYDX products in the marketplace. If anything will attract new investors, it is PRs. This will generate demand for position in the company thus increasing sp. Sp does not always increase with PR releases. Ultimately, it all comes down to how much investors believe MYDX will be worth in 5 years. Anyone that believes MYDX will be worth less than a billion dollars in 5 years, really is hoping MYDX isn't worth that much in 5 years is how I feel about it. MYDX investors have more FACTS to sustain an argument that MYDX will be uplisted to NASDAQ in 5 or less years, than others have that MYDX will be bankrupt in 5 years. Speculation is a waste of time and effort. Facts are in favor of MYDX and as long as fins improve each quarter over all, there is no reason to believe MYDX is not NASDAQ bound.
This is my last free message for the day. Good green day for MYDX!
MYDX will only continue to increase in value through that date and beyond. MYDX products are designed to help people who want to live a better life live a better life and All products can potentially save lives and when they do, that's what makes headlines!
It means MYDX will make headline news on every major syndicate and mediums that communicate useful info for its listeners, viewers and readers. It's only a matter of time and MYDX wouldn't have paid for any of it!!
Right on, man, right on.
I appreciate all of yalls insights throughout the months of finding MYDX. Anything I can offer is motivated by that. Thank you all!!
My position would be triple the value if My brokerage traded subpenny when I found MYDX back in March when it was at .0086. I will continue to buy though the end of the year and beyond!
Today could be the last opportunity to begin or continue a long position in MYDX! With the right investors doing real DD overnight long hours, we should be able to see .02 today but this is a great weekend to steadily study, research, DD the heck out of MYDX and Monday and all next week should be fantastic for MYDX investors moving forward.
I have no reason to believe Montreal is out of the Canadian market. MYDX knows which provinces to campaign first. The question isn't why not Montreal because so many others are being left out, the question instead should be why Toronto and Vancouver and Ontario?
FACTS are in favor of MYDX, very good for investors the remainder of this year and years to come I believe.
I don't see where it says that in the snipit.
There are MyDX associates you can ask those questions to who have the answers you're looking for.